                                                   5
         Abstract
         Medicine     synthesis intermediates benzoyl      formic acid synthesis method,
   comprises      the   following   steps:  the   reaction    vessel  was    added   3   mol
 5 1-phenyl-2-bromoethanol, 6-8 mol p-propiolactone solution, raising the temperature
   of the solution to 50-60'C, controlling the stirring speed at 190-230 rpm, added
   tetraethyl titanate in 4 times, each time for 5-8 min, interval for 30-40 min, reacted for
   90-120 min, precipitated the solid, filtrated, washed with sodium bromide solution,
   combined filtrate and washing solution, added sodium bisulfate solution, adjusted the
10 pH to 4-6, extracted with 2-methyl-3-pentanone solution for 3-6 times, extracted with
   2-methyl pentane solution for 5-8 times, recrystallizated in 1-methyl naphthalene
   solution, dehydrated with dehydration, got the finished benzoyl formic acid.

                                                  1
             Medicine synthesis intermediates benzoyl formic acid synthesis method
         FIELD OF THE INVENTION
         The present invention relates to medicine synthesis intermediates benzoyl formic
 5 acid synthesis method.
         GENERAL BACKGROUND
         Benzoyl formic acid is a kind of compounds containing carbonyl, carboxylic acid
   and ester groups, belonging to a-keto acid esters compounds. Because of its many
   active groups, and show a variety of special properties, it can be used to synthesize
10 important pharmaceutical intermediates with a variety of reagents. However, most of
   the existing synthetic methods are using benzoyl nitrile which is catalyzed by
   concentrated hydrochloric acid, hydrolysis to produce benzoyl formic acid, it is
   complicated and the final yield is not very high. Therefore, it is necessary to propose a
   new synthetic method for further improving the quality and yield of the product and
15 reducing the byproduct content, it has important economic significance.
         SUMMARY
         The purpose of the present invention is to provide medicine synthesis
   intermediates benzoyl formic acid synthesis method, comprises the following steps:
20       (i) the reaction vessel was added 3 mol 1-phenyl-2-bromoethanol, 6-8 mol
   p-propiolactone solution, raising the temperature of the solution to 50-60 C, controlling
   the stirring speed at 190-230 rpm, added tetraethyl titanate in 4 times, each time for 5-8
   min, interval for 30-40 min, reacted for 90-120 min, precipitated the solid, filtrated,
   washed with sodium bromide solution, combined filtrate and washing solution, added
25 sodium bisulfate solution, adjusted the pH to 4-6, extracted with 2-methyl-3-pentanone
   solution for 3-6 times, extracted with 2-methyl pentane solution for 5-8 times,
   recrystallizated in 1-methyl naphthalene solution, dehydrated with dehydration, got the
   finished benzoyl formic acid; wherein, the mass fraction of the p-propiolactone
   solution described in step (i) is 80 to 86%, the mass fraction of the sodium bromide
30 solution described in step (i) is 30 to 37%, the mass fraction of sodium bisulfate

                                                    2
   solution described in step (i) is 20-26%, the mass fraction of the 2-methyl-3-pentanone
   solution of step (i) is 70-78%, the mass fraction of the 2-methylpentane solution in step
   (i) is 80-85%, and the mass fraction of the 1-methylnaphthalene solution in step (i) is
   92-96%.
 5       Throughout the reaction process can be the following reaction formula:
                           CH+    C3H 4O2   +   C0'10O4Ti                                 COCH
                           Br
         Advantage of the present invention is that: reducing intermediate links reaction,
   decreasing the reaction time and improving the reaction yield.
10       DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
         The following examples with reference to specific embodiments of the present
   invention are further illustrated:
         medicine synthesis intermediates benzoyl formic acid synthesis method.
15       Embodiment 1
         The reaction vessel was added 3 mol 1-phenyl-2-bromoethanol,                 6 mol
   p-propiolactone   solution with mass fraction of 80%, raising the temperature of the
   solution to 50 C, controlling the stirring speed at 190 rpm, added tetraethyl titanate in 4
   times, each time for 5 min, interval for 30 min, reacted for 90 min, precipitated the
20 solid, filtrated, washed with sodium bromide solution with mass fraction of 30%,
   combined filtrate and washing solution, added sodium bisulfate solution with mass
   fraction of 20%, adjusted the pH to 4, extracted with 2-methyl-3-pentanone solution
   with mass fraction of 70% for 3 times, extracted with 2-methyl pentane solution with
   mass fraction of 80% for 5 times, recrystallizated in 1-methyl naphthalene solution
25 with mass fraction of 92%, dehydrated with anhydrous calcium sulphate dehydration,
   got the finished benzoyl formic acid 409.5g,yield of 91%.

                                                    3
         Embodiment 2
         The reaction vessel was added 3 mol 1-phenyl-2-bromoethanol, 7 mol
     -propiolactone solution with mass fraction of 83%, raising the temperature of the
   solution to 55'C, controlling the stirring speed at 210 rpm, added tetraethyl titanate in 3
 5 times, each time for 6 min, interval for 35 min, reacted for 110 min, precipitated the
   solid, filtrated, washed with sodium bromide solution with mass fraction of 33%,
   combined filtrate and washing solution, added sodium bisulfate solution with mass
   fraction of 23%, adjusted the pH to 5, extracted with 2-methyl-3-pentanone solution
   with mass fraction of 73% for 5 times, extracted with 2-methyl pentane solution with
10 mass fraction of 82% for 6 times, recrystallizated in 1-methyl naphthalene solution
   with mass fraction of 94%, dehydrated with anhydrous potassium carbonate
   dehydration, got the finished benzoyl formic acid 418.5g,yield of 93%.
         Embodiment 3
15       The reaction vessel was added 3 mol 1-phenyl-2-bromoethanol,                  8 mol
   p-propiolactone solution with mass fraction of 86%, raising the temperature of the
   solution to 60 'C, controlling the stirring speed at 230 rpm, added tetraethyl titanate in 4
   times, each time for 8 min, interval for 40 min, reacted for 120 min, precipitated the
   solid, filtrated, washed with sodium bromide solution with mass fraction of 37%,
20 combined filtrate and washing solution, added sodium bisulfate solution with mass
   fraction of 26%, adjusted the pH to 6, extracted with 2-methyl-3-pentanone solution
   with mass fraction of 78% for 6 times, extracted with 2-methyl pentane solution with
   mass fraction of 85% for 8 times, recrystallizated in 1-methyl naphthalene solution
   with mass fraction of 96%, dehydrated with dehydration, got the finished benzoyl
25 formic acid 432g,yield of 96%.

                                                 4
          Claims
          1. Medicine synthesis intermediates benzoyl formic acid synthesis method,
   comprises the following steps:
          (i) the reaction vessel was added 3 mol 1-phenyl-2-bromoethanol, 6-8 mol
 5 s-propiolactone     solution, raising the temperature of the solution to 50-60 C ,
   controlling the stirring speed at 190-230 rpm, added tetraethyl titanate in 4 times, each
   time for 5-8 min, interval for 30-40 min, reacted for 90-120 min, precipitated the solid,
   filtrated, washed with sodium bromide solution, combined filtrate and washing
   solution, added sodium bisulfate solution, adjusted the pH to 4-6, extracted with
10 2-methyl-3-pentanone       solution for 3-6 times, extracted with 2-methyl pentane
   solution for 5-8 times, recrystallizated in 1-methyl naphthalene solution, dehydrated
   with dehydration, got the finished benzoyl formic acid; wherein, the mass fraction of
   the p-propiolactone solution described in step (i) is 80 to 86%, the mass fraction of the
   sodium bromide solution described in step (i) is 30 to 37%, the mass fraction of
15 sodium bisulfate solution described in step (i) is 20-26%, the mass fraction of the
   2-methyl-3-pentanone solution of step (i) is 70-78%.
          2. Medicine synthesis intermediates benzoyl formic acid synthesis method
   according to claim 1 wherein the mass fraction of the 2-methylpentane solution in step
20 (i) is 80-85%.
          3. Medicine synthesis intermediates benzoyl formic acid synthesis method
   according to claim 1 wherein the mass fraction of the 1-methylnaphthalene solution in
   step (i) is 92-96%.

